Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2020 | COVID-19 and the NHS

Wendy Osborne • 2 Jun 2020
EHA 2020
Diffuse Large B-Cell Lymphoma General Lymphoma

Wendy Osborne, MBBS (Hons), MRCP, FRCPath, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK, discusses the impact of COVID-19 on patient care in the UK’s National Health Service (NHS). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Wendy Osborne

2:03
Novel treatment approaches for early-stage DLBCL
Wendy Osborne • 24 Apr 2023
1:20
Improving patient outcomes in CTCL: clinical collaboration and novel agents
Wendy Osborne • 24 Apr 2023
2:19
Session highlights: autoSCT in T-cell lymphoma, classification updates and fertility preservation
Wendy Osborne • 24 Apr 2023
1:01
Pitfalls in the diagnosis of lymphoid malignancies: interpreting PET scans
Wendy Osborne • 24 Apr 2023

Related Videos

4:07
Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD
Florent Malard • 11 Apr 2024
5:23
Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD
Mohamad Mohty • 17 Apr 2024
2:00
HHV-6 reactivation after haploidentical transplantation with PTCy & ATG: incidence and risk factors
Rémy Duléry • 15 Apr 2024
1:41
The consequences of regulatory changes on access to devices and reagents needed for graft processing
Christian Chabannon • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals